Spironolactone + Dapagliflozin
Sponsors
Universidade do Porto, University College, London
Conditions
Aortic StenosisHeart Failure With Preserved Ejection Fraction
Phase 2
Dapagliflozin With or Without Spironolactone for HFpEF
CompletedNCT05676684
Start: 2022-09-15End: 2024-11-29Updated: 2025-08-17
To Establish Whether Dapagliflozin and Spironolactone in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement, Result in Better Left Ventricular Mass Regression, Myocardial Health and Patient Reported Outcomes
Not yet recruitingNCT07539259
Start: 2026-12-01End: 2030-02-28Target: 445Updated: 2026-05-18